UAS
HALO icon

United Asset Strategies’s Halozyme HALO Stock Holding History

United Asset Strategies’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-27,466
Closed -$1.12M – 219
2021
Q3 		$1.12M Buy
27,466
+6,064
+28% +$254K 0.14% 109
2021
Q2 		$972K Buy
21,402
+2,301
+12% +$102K 0.13% 115
2021
Q1 		$796K Buy
+19,101
New +$872K 0.12% 124

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

United Asset Strategies's HALO Position: Q4 2021 in Review

United Asset Strategies sold out of Halozyme (HALO) in Q4 2021, closing a stake of 27,466 shares — an estimated $1.12M sold.

United Asset Strategies first reported a position in HALO in Q1 2021 and held it in 3 quarters. The position peaked at $1.12M in Q3 2021. 324 funds tracked by Wall St. Rank hold HALO as of Q4 2021.

  • United Asset Strategies reported no remaining Halozyme position as of Q4 2021 after selling out during the quarter.
  • United Asset Strategies sold 27,466 Halozyme shares in Q4 2021, an estimated $1.12M.
  • United Asset Strategies first reported a position in Halozyme in Q1 2021 and held it in 3 quarters.
  • United Asset Strategies's Halozyme position peaked at $1.12M in Q3 2021.
  • 324 funds tracked by Wall St. Rank held Halozyme as of Q4 2021.

Based on United Asset Strategies's 13F filing for Q4 2021, filed 31 Jan 2022.